Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Thermo Fisher Posts 3% Q2 Rise

TheMotleyFool 
0 0 29.07.25
Thermo Fisher Posts 3% Q2 Rise
 

Thermo Fisher Scientific (NYSE:TMO), a leading provider of scientific instrumentation, reagents and consumables, and specialty diagnostics, reported its second quarter results for fiscal 2025 on July 23, 2025. The company delivered higher revenue and non-GAAP earnings per share than Wall Street estimates, with revenue (GAAP) was $10.85 billion versus the $10.68 billion analyst consensus, and Adjusted EPS was $5.36 against a $5.23 estimate. While overall revenue (GAAP) grew and product launches remained strong, profit margins again fell from last year. The quarter reflected the company’s innovation and ability to navigate a complicated policy and demand environment, despite ongoing pressures.

Source: Analyst estimates for the quarter provided by FactSet.

Thermo Fisher Scientific is a global science and diagnostics company serving pharmaceutical, biotechnology, healthcare, academic, and government customers. It is known for instruments, chemicals, and clinical diagnostic tools that support laboratory research, drug manufacturing, and clinical care.

Continue reading


Source Fool.com

Electro Power Systems S.A. Stock

Show more
Like: 0
TMO
Share

Comments

Not a member yet? Sign up for free!